Theragenics CEO Discusses Q2 2011 Results - Earnings Call Transcript

Theragenics Corp. (TGX)

Q2 2011 Earnings Conference Call

August 11, 2011 11:00 AM ET

Executives

Christine Jacobs – Chairman and CEO

Frank Tarallo – CFO

Analysts

Brett Reiss – Janney Montomery Scott

Joe Munda – Sidoti & Company

Presentation

Operator

Compare to:
Previous Statements by TGX
» Theragenics' CEO Discusses Q1 2011 Results - Earnings Call Transcript
» Theragenics Corporation CEO Discusses Q4 2010 Results - Earnings Call Transcript
» Theragenics CEO Discusses Q3 2010 Results - Earnings Call Transcript
» Theragenics Corporation Q2 2010 Earnings Call Transcript

Greetings. And welcome to the Theragenics Corporation Second Quarter 2011 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions)

As a reminder, this conference is being recorded. It is now my pleasure to introduce Christine Jacobs, Chairman and CEO of Theragenics. Thank you, Ms. Jacobs. You may begin.

Christine Jacobs

Thank you, Claudia. Good morning. And welcome to our Theragenics second quarter 2011 conference call. Thank you for joining us today. In just a few minutes, I’ll provide some comments on the quarter but first I’m going to ask Frank Tarallo, our Chief Financial Officer to provide the review of the financials. Frank?

Frank Tarallo

Thank you, Chris. This morning we released our consolidated financial results for second quarter of 2011. If you did not receive this new release or if you like to be added to either our fax or email distribution list, please contact Investor Relations at 800-998-8479 or 770-271-0233.

Before I begin my review, please be aware that some comments made during this conference call may contain forward-looking statements involving risks and uncertainties regarding our operations and future results. Please see our press release issued today and our filings with the Securities and Exchange Commission, including without limitation, the company’s Form 10-K and Forms 10-Q, which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

1 2 3 Next › Last »